Alnylam

Alnylam Drug Scores Against Rare Nerve Disease
Investors.com
Mon, 10/13/14 - 04:02 pm
Alnylam
Patisiran
familial amyloid polyneuropathy
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Alnylam Starts New Study on Cardiac Amyloidosis Patients
Yahoo/Zacks
Sat, 09/27/14 - 09:28 am
Alnylam
cardiac amyloidosis
ALN-TTRsc
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
24/7 Wall St
Thu, 09/25/14 - 09:21 am
orphan drugs
Alnylam
Biomarin
Alexion
Isis Pharmaceuticals
Vertex Pharmaceuticals
Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus
Yahoo/Zacks.com
Mon, 08/11/14 - 11:53 am
earnings
Alnylam
Insider Selling: John K. Clarke Sells 35,000 Shares of Alnylam Pharmaceuticals Stock (ALNY)
WKRB13
Mon, 05/26/14 - 08:37 am
Alnylam
Alnylam announces publication of pre-clinical results with ALN-AS1
The Fly on the Wall
Wed, 05/21/14 - 11:23 am
Alnylam
ALN-AS1
hepatic porphyrias
Biotech M&A is MIA
TheStreet.com
Mon, 04/28/14 - 10:18 am
M&A
biotech
Pfizer
Alnylam
Biogen Idec
Celgene
GSK
Novartis
AstraZeneca
Allergan
Valeant Pharmaceuticals
Alnylam Strikes Back: Comments From CEO John Maraganore
Forbes
Wed, 04/23/14 - 10:19 am
Pharma CEOs
John Maraganore
Alnylam
RNAi
Big Pharma's Turn On RNAi Shows That New Technologies Don't Guarantee R&D Success
Forbes
Tue, 04/15/14 - 10:35 am
Big Pharma
RNAi
Novartis
Alnylam
Alnylam: Biotech on the Verge of a Breakout
TheStreet.com
Fri, 02/21/14 - 09:27 am
Alnylam
Rise of Alnylam, ISIS Gives RNA Therapeutics Value
Wall St Cheat Sheet
Wed, 02/19/14 - 10:17 am
Alnylam
Isis Pharmaceuticals
RNAi
Alnylam Widens Q4 Loss
Yahoo/Zacks.com
Fri, 02/14/14 - 12:46 pm
Alnylam
earnings
Merck's RNAi Trash is Alnylam's Treasure
Motley Fool
Fri, 01/24/14 - 09:10 am
Merck
RNAi
Alnylam
patents
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wed, 01/22/14 - 04:14 pm
Sarepta Therapeutics
Alnylam
Jazz Pharmaceuticals
Regeneron
Celgene
Alnylam Snaps Up Merck’s Sirna Therapeutics
Wall St Cheat Sheet
Mon, 01/13/14 - 02:51 pm
siRNA
M&A
Merck
Alnylam
RNAi
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
Sanofi Pays $700 Million for Alnylam Drugs and Stake
Bloomberg
Mon, 01/13/14 - 08:47 am
Sanofi
Alnylam
Patisiran
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:52 pm
RNAi
Alnylam
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:51 pm
Alnylam
RNAi

Pages